Abstract
Public health disease prevention programs have expanded newborn screening to most nations, although lack of access to prenatal and birth care continues to be a major challenge to improving child health and reducing morbidity/mortality in poor, rural, and other disadvantaged regions. Newborn screening involves collection of a few blood spots from a newborn infant’s heel, followed by rapid laboratory analysis, often at a centralized testing facility, and relaying of the test results to the pediatrician for appropriate action. Such testing and rapid reporting are important for some genetic conditions such as phenylketonuria and classical galactosemia, where failure to provide treatment and restricted diets within days can result in severe brain damage, permanent disability, and/or death. Newborn screening started in the 1970s with a core set of tested conditions, including phenylketonuria, sickle-cell anemia and other hemoglobinopathies, galactosemia, and congenital hypothyroidism. Beginning around 2000, the invention of Tandem Mass Spectrometry enabled testing of a wide array of additional amino acid, organic acid, and fatty acid metabolic conditions so that currently in the United States, more than 50 genetic or metabolic conditions are tested. An overview of many of these screened conditions is provided along with resources for more information, although the number of documented, different conditions numbers in the thousands, most of which cannot be diagnosed with current newborn screening technology. The provided resources provide excellent details and emphasize the importance of proper prenatal and postnatal pediatric care and monitoring to identify these conditions if they arise. Most conditions are treatable with proper nutritional restrictions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CoA:
-
Coenzyme A
- CF:
-
Cystic Fibrosis
- DNA:
-
Deoxyribonucleic Acid
- G6PDD:
-
Glucose 6 Phosphate Dehydrogenase Deficiency
- LCADD:
-
Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency
- LCHADD:
-
Long-Chain Hydroxy Acyl-Coenzyme A Dehydrogenase Deficiency
- MCADD:
-
Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency
- MCKAT:
-
Medium-Chain 3-Ketoacyl-Coenzyme A Thiolase
- MSUD:
-
Maple Syrup Urine Disease
- SCADD:
-
Short-Chain Acyl-Coenzyme A Dehydrogenase Deficiency
- SCHADD:
-
Short-Chain HydroxyAcyl-Coenzyme A Dehydrogenase Deficiency
- NAD:
-
Nicotinamide Adenine Dinucleotide
- OMIM® :
-
Online Mendelian Inheritance in Man
- RNA:
-
Ribonucleic Acid
References
Ampola, M. G., Mahoney, M. J., Nakamura, E., & Tanaka, K. (1975). Prenatal therapy of a patient with vitamin-B12 responsive methylmalonic acidemia. The New England Journal of Medicine, 293, 313–317.
Andresen, B. S., Dobrowolski, S. F., O’Reilly, L., Muenzer, J., McCandless, S. E., Frazier, D. M., Udvari, S., Bross, P., Knudsen, I., Banas, R., Chace, D. H., Engel, P., Naylor, E. W., & Gregersen, N. (2001). Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: Identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. American Journal of Human Genetics, 68(6), 1408–1418.
Baric, I., Fumic, K., Glenn, B., Cuk, M., Schulze, A., Finkelstein, J. D., James, S. J., Mejaski-Bosnjak, V., Pazanin, L., Pogribny, I. P., Rados, M., Sarnavka, V., Scukanec-Spoljar, M., Allen, R. H., Stabler, S., Uzelac, L., Vugrek, O., Wagner, C., Zeisel, S., & Mudd, S. H. (2004). S-adenosylhomocysteine hydrolase deficiency in a human: A genetic disorder of methionine metabolism. Proceedings of the National Academy of Sciences USA, 101(12), 4234–4239.
Carmichael, M. (2011). Newborn screening: A spot of trouble. Nature, 475, 156–158.
Crowley, R., Wolfe, I., Lock, K., & McKee, M. (2011). Improving the transition between paediatric and adult healthcare: A systematic review. Archives of Disease in Childhood, 96, 548–553.
Das, A. M., Illsinger, S., Lucke, T., Hartmann, H., Ruiter, J. P. N., Steuerwald, U., Waterham, H. R., Duran, M., & Wanders, R. J. A. (2006). Isolated mitochondrial long-chain ketoacyl-CoA thiolase deficiency resulting from mutations in the HADHB gene. Clinical Chemistry, 52(3), 530–534.
Egan, T. M., Detterbeck, F. C., Mill, M. R., Paradowski, L. J., Lackner, R. P., Ogden, W. D., Yankaskas, J. R., Westerman, J. H., Thompson, J. T., Weiner, M. A., Cairns, E. L., & Wilcox, B. R. (1995). Improved results of lung transplantation for patients with cystic fibrosis. The Journal of Cardiovascular Surgery, 109, 224–235.
Flanagan, J. L., Simmons, P. A., Vehige, J., Willcox, M. D. P., & Garrett, Q. (2010). Role of carnitine in disease. Nutrition & Metabolism, 7, 30.
Forest, M. G., Betuel, H., & David, M. (1989). Prenatal treatment in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Up-date 88 of the French multicentric study. Endocrine Research, 15(1–2), 277–301.
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suner, D., Cigudosa, J. C., Urioste, M., Benitez, J., Boix-Chornet, M., Sanchez-Aguilera, A., Ling, C., Carlsson, E., Poulsen, P., Vaag, A., Stephan, Z., Spector, T. D., Wu, Y.-Z., Plass, C., & Esteller, M. (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proceedings of the National Academy of Sciences USA, 102(30), 10604–10609.
Gardner, E. J., & Snustad, D. P. (1984). Principles of genetics (7th ed.). New York: Wiley.
Genetics & Public Policy Center. (2005). Public awareness and attitudes about reproductive genetic technology. Washington: Genetics & Public Policy Center, Johns Hopkins University.
Gjessing, L. R., Lunde, H. A., Undrum, T., Broch, H., Alme, A., & Lie, S.O. (1986). A new patient with hyperornithinaemia, hyperammonaemia and homocitrullinuria treated early with low protein diet. Journal of Inherited Metabolic Disease, 9(2), 186–192.
Gupta, S. (2011). Ethical debate over fatal disease for newborns. www.cbsnews.com. Accessed 17 June 2011 (Published 16 June 2001).
Haworth, J. C., Demaugre, F., Booth, F. A., Dilling, L. A., Moroz, S. P., Seshia, S. S., Seargeant, L. E., & Coates, P. M. (1992). Atypical features of the hepatic form of carnitine palmitoyltransferase deficiency in a Hutterite family. Journal of Pediatrics, 121(4), 553–557.
Hollar D. (2009). Progress along developmental tracks for electronic health records implementation in the United States. Health Research Policy and Systems, 7, 3.
Hollar, D. W., Lozzio, C., Eubanks, R. L., & Evans, M. (2005). The key elements in partnership and infrastructure development for electronic child health profiles: A description of two parallel, complementary projects. The 133rd American public health association annual meeting, Philadelphia, 9–14 Dec 2005.
Ibdah, J. A., Bennett, M. J., Rinaldo, P., Zhao, Y., Gkibson, B., Sims, H. F., & Strauss, A. W. (1999). A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. The New England Journal of Medicine, 340, 1723–1731.
Johnson, K. B. (2001). Barriers that impede the adoption of pediatric information technology. Archives of Pediatrics & Adolescent Medicine, 155, 1374–1379.
Jones, P. M., Butt, Y., & Bennett, M. J. (2003). Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: Implications for medium chain triglyceride dietary treatment of LCHAD deficiency. Pediatric Research, 53, 783–787.
Kamijo, T., Indo, Y., Souri, M., Aoyama, T., Hara, T., Yamamoto, S., Ushikubo, S., Rinaldo, P., Matsuda, I., Komiyama, A., & Hashimoto, T. (1997). Medium chain 3-ketoacyl-coenzyme A thiolase deficiency: A new disorder of mitochondrial fatty acid beta-oxidation. Pediatric Research, 42(5), 569–576.
Kaye, C.I., & Committee on Genetics. (2006). Newborn screening fact sheets. Pediatrics, 118, 934–963.
Koizumi, A., Nozaki, J., Ohura, T., Kayo, T., Wada, Y., Nezu, J., Ohashi, R., Tamai, I., Shoji, Y., Takada, G., Kibira, S., Matsuishi, T., & Tsuji, A. (1999). Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Human Molecular Genetics, 8, 2247–2254.
Kolker, S., Christensen, E., Leonard, J. V., Greenberg, C. R., Burlina, A. B., Burlina, A. P., Dixon, M., Duran, M., Goodman, S. I., Koeller, D. M., Muller, E., Naughten, E. R., Neumaier-Probst, E., Okun, J. G., Kyllerman, M., Surtees, R. A., Wilcken, B., Hoffmann, G. F., & Burgard, P. (2007). Guideline for the diagnosis and management of gultaryl-CoA dehydrogenase deficiency (glutaric aciduria type I). Journal of Inherited Metabolic Disease, 30(1), 5–22.
Labrune, P., Perignon, J. L., Rault, M., Brunet, C., Lutun, H., Charpentier, C., Saudubray, J. M., & Odievre, M. (1990). Familial hypermethioninemia partially responsive to dietary restriction. Journal of Pediatrics, 117(2, Pt. 1), 220–226.
Lamhonwah, A. M., Olpin, S. E., Pollitt, R. J., Vianey-Saban, C., Divry, P., Guffon, N., Besley, G. T., Onizuka, R., de Meirleir, L. J., Cvitanovic-Sojat, L., Baric, I., Dionisi-Vici, C., Fumic, K., Maradin, M., & Tein, I. (2002). Novel OCTN2 mutations: No genotype-phenotype correlations: Early carnitine therapy prevents cardiomyopathy. American Journal of Human Genetics, 111(3), 271–284.
Lewis, M. H., Goldenberg, A., Anderson, R., Rothwell, E., & Botkin, J. (2011). State laws regarding the retention and use of residual newborn screening blood samples. Pediatrics, 127(4), 703–712.
Maestri, N. E., Hauser, E. R., Bartholomew, D., & Brusilow, S. W. (1991). Prospective treatment of urea cycle disorders. Journal of Pediatrics, 119(6), 923–928.
Marieb, E. N. (2001). Human anatomy & physiology (5th ed.). San Francisco: Benjamin Cummings.
McKusick, V. A. (1966). Mendelian inheritance in man: Catalogs of autsomal dominant, autosomal recessive, and X-linked phenotypes, (1st ed.). Baltimore: Johns Hopkins University Press.
McKusick, V. A. (1990). Mendelian inheritance in man: Catalogs of autsomal dominant, autosomal recessive, and X-linked phenotypes, (9th ed.). Baltimore: Johns Hopkins University Press.
McKusick, V. A. (1998). Mendelian inheritance in man: Catalogs of autsomal dominant, autosomal recessive, and X-linked phenotypes (12th ed.). Baltimore: Johns Hopkins University Press.
Naglak, M., Salvo, R., Madsen, K., Dembure, P., & Elsas, L. (1988). The treatment of isovaleric acidemia with glycine supplement. Pediatric Research, 24(1), 9–13.
Nature. (2011). Editorial: There will be blood. Nature, 475, 139.
Nishikimi, M., & Yagi, K. (1991). Molecular basis for the deficiency in humans of gulonolactone oxidase, a key enzyme for ascorbic acid biosynthesis. The American Journal of Clinical Nutrition, 54, 1203S–1208S.
Pearson, H. (2002). Immunity’s pregnant pause. Nature, 420, 265–266.
Pembrey, M. E., Bygren, L. O., Kaati, G., Edvinsson, S., Northstone, K., Sjostrom, M., Golding, J., & ALSPAC Study Team. (2006). Sex-specific, male-line transgenerational responses in humans. European Journal of Human Genetics, 14, 159–166.
Pinna, A., Carru, C., Solinas, G., Zinellu, A., & Carta, F. (2007). Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion. Investigative Ophthalmology & Visual Science, 48(6), 2747–2752.
Pollitt, R. J., & Leonard, J. V. (1998). Prospective surveillance study of medium-chain acyl-CoA dehydrogenase deficiency in the UK. Archives of Dermatological Research, 79(2), 116–119.
Qureshi, I. A., Letarte, J., Quellet, R., Batshaw, M. L., & Brusilow, S. (1984). Treatment of hyperargininemia with sodium benzoate and arginine-restricted diet. Journal of Pediatrics, 104(3), 473–476.
Rimmer, J. H., Yamaki, K., Davis Lowry, B. M., Wang, E., & Vogel, L. C. (2010). Obesity and obesity-related secondary conditions in adolescents with intellectual/developmental disabilities. Journal of Intellectual Disability Research, 54(9), 787–794.
Ristoff, E., Mayatepek, E., & Larsson, A. (2001). Long-term clinical outcome in patients with glutathione synthetase deficiency. Journal of Pediatrics, 139(1), 79–84.
Roche/Swiss Institute. (2011). ExPASy bioinformatics resource portal, biochemical pathway maps. Geneva: Swiss Institute of Bioinformatics. http://web.expasy.org/pathways. Accessed 8 Aug 2011.
Rodes, M., Ribes, A., Pineda, M., Alvarez, L., Fabregas, I., Fernandez Alvarez, E., Coude, F. X., & Grimber, G. (1987). A new family affected by the syndrome of hyperornithinaemia, hyperammonaemia and homocitrullinuria. Journal of Inherited Metabolic Disease, 10(1), 73–81.
Roe, C. R., Millington, D. S., Maltby, D. A., & Kinnebrew, P. (1986). Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes. Journal of Pediatrics, 108(1), 13–18.
Stanley, C. A. (2004). Carnitine deficiency disorders in children. Annals of the New York Academy of Sciences, 1033, 42–51.
Stryer, L. (1995). Biochemistry (4th ed.). New York: Freeman.
Symonds, M. E. (2010). Epigenomics—Grand challenge: Much more than the developmental origins of adult health and disease. Front Genetics, 1, 1–2.
Tarini, B. A., Goldenberg, A., Singer, D., Clark, S. J., Butchart, A., & Davis, M. M. (2010). Not without my permission: Parents’ willingness to permit use of newborn screening samples for research. Public Health Genomics, 13(3), 125–130.
Testai, F. D., & Gorelick, P. B. (2010). Inherited metabolic disorders and stroke part 2: Homocystinuria, organic acidurias, and urea cycle disorders. Archives of Neurology, 67(2), 148–153.
Thorpe, C., & Kim, J.-J. P. (1995). Structure and mechanism of action of the Acyl-CoA dehydrogenases. FASEB Journal, 9, 718–725.
Treem, W. R., Stanley, C. A., & Goodman, S. I. (1989). Medium-chain acyl-CoA dehydrogenase deficiency: Metabolic effects and therapeutic efficacy of long-term L-carnitine supplementation. Journal of Inherited Metabolic Disease, 12, 112–119.
Trompeter, S., & Roberts, I. (2008). Haemoglobin F modulation in childhood sickle cell disease. British Journal of Haematology, 144(3), 308–316.
Tuchman, L. K., Schwartz, L. A., Sawicki, G. S., & Britto, M. T. (2010). Cystic fibrosis and transition to adult medical care. Pediatrics, 125, 566–573.
Williams, R. J. (1956). Biochemical individuality. New York: Wiley.
Wolpert, L., Tickle, C., Lawrence, P., Meyerowitz, E., Robertson, E., Smith, J., & Jessell, T. (2011). Principles of development (4th ed.). New York: Oxford University Press.
Wong, P., Lessick, M., Kang, S., & Nelson, M. (1989). Maternal hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome. American Journal of Human Genetics, 45(Suppl.), A14.
Yankaskas, J. R., & Mallory, G. B., Consensus Committee. (1998). Lung transplantation in cystic fibrosis: Consensus conference statement. Chest, 113, 217–226.
Zschocke, J., Quak, E., Guldberg, P., & Hoffmann, G. F. (2000). Mutation analysis in glutaric aciduria type I. Journal of Medical Genetics, 37, 177–181.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hollar, D. (2012). Genetic and Metabolic Conditions for Children with Special Health Care Needs. In: Hollar, D. (eds) Handbook of Children with Special Health Care Needs. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2335-5_14
Download citation
DOI: https://doi.org/10.1007/978-1-4614-2335-5_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-2334-8
Online ISBN: 978-1-4614-2335-5
eBook Packages: MedicineMedicine (R0)